Table of Contents
1. Market Overview
2. Market Risks and Trends Assessment
3. Market Background and Foundation Data Points
4. Key Success Factors
5. Global Market Value Analysis 2018 to 2022 and Forecast 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Disorder
- 6.1. Peripheral Neuropathy
- 6.2. Autonomic Neuropathy
- 6.3. Proximal Neuropathy
- 6.4. Focal Neuropathy
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Treatment
- 7.1. Drug
- 7.1.1. Analgesic
- 7.1.1.1. Topical
- 7.1.1.1.1. Capsaicin
- 7.1.1.1.2. Others
- 7.1.1.2. Opioids
- 7.1.1.2.1. Morphine
- 7.1.1.2.2. Others
- 7.1.1.3. NSAIDs
- 7.1.1.3.1. Ibuprofen
- 7.1.1.3.2. Naproxen
- 7.1.1.3.3. Others
- 7.1.1.1. Topical
- 7.1.2. Antidepressant
- 7.1.2.1. TCAs
- 7.1.2.1.1. Amitriptyline
- 7.1.2.1.2. Imipramine
- 7.1.2.1.3. Others
- 7.1.2.2. SNRIs
- 7.1.2.2.1. Duloxetine
- 7.1.2.2.2. Others
- 7.1.2.3. SSRIs
- 7.1.2.3.1. Citalopram
- 7.1.2.3.2. Paroxetin
- 7.1.2.3.3. Others
- 7.1.2.1. TCAs
- 7.1.3. Anticonvulsants
- 7.1.3.1. Gabapentin
- 7.1.3.2. Pregabalin
- 7.1.3.3. Topimarate
- 7.1.3.4. Others
- 7.1.3.5. Other Drugs
- 7.1.1. Analgesic
- 7.2. Radiotherapy
- 7.2.1. TENS
- 7.2.2. Others
- 7.3. Physiotherapy
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
- 8.1. Hospitals
- 8.2. Clinics
- 8.3. Retail Pharmacy
- 8.4. Online Pharmacy
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Europe
- 9.4. Asia Pacific
- 9.5. Middle East and Africa (MEA)
10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033
13. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033
14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033
15. Market Structure Analysis
16. Competition Analysis
- 16.1. Johnson & Johnson (Janssen Global Services, LLC)
- 16.2. Boehringer Ingelheim GmbH
- 16.3. NeuroMetrix, Inc
- 16.4. Eli Lilly and Company
- 16.5. GlaxoSmithKline plc
- 16.6. Lupin Limited
- 16.7. Pfizer Inc
- 16.8. Astellas Pharma Inc
- 16.9. Glenmark Pharmaceuticals Ltd
- 16.10. Arbor Pharmaceuticals, LLC
- 16.11. Depomed, Inc
- 16.12. Other Prominent Players
17. Assumptions and Acronyms Used
18. Research Methodology
List of Tables
Table 01: Global Market Value (US$ Mn) Analysis, by Disorder, 2018 to 2022
Table 02: Global Market Value (US$ Mn) Analysis, by Disorder, 2023 to 2033
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Disorder, 2018 to 2022
Table 04: Global Market Value (US$ Mn) Opportunity Analysis, by Disorder, 2023 to 2033
Table 05: Global Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022
Table 06: Global Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033
Table 07: Global Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2018 to 2022
Table 08: Global Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033
Table 09: Global Market Value (US$ Mn) Analysis, by Distribution Channel, 2018 to 2022
Table 10: Global Market Value (US$ Mn) Analysis, by Distribution Channel, 2023 to 2033
Table 11: Global Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2018 to 2022
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2023 to 2033
Table 13: Global Market Value (US$ Mn) Analysis, by Region, 2018 to 2022
Table 14: Global Market Value (US$ Mn) Analysis, by Region, 2023 to 2033
Table 15: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2018 to 2022
Table 16: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2023 to 2033
Table 17: North America Market Value (US$ Mn) Analysis, by Region, 2018 to 2022
Table 18: North America Market Value (US$ Mn) Analysis, by Region, 2023 to 2033
Table 19: North America Market Value (US$ Mn) Opportunity Analysis, by Region, 2018 to 2022
Table 20: North America Market Value (US$ Mn) Opportunity Analysis, by Region, 2023 to 2033
Table 21: North America Market Value (US$ Mn) Analysis, by Disorder, 2018 to 2022
Table 22: North America Market Value (US$ Mn) Analysis, by Disorder, 2023 to 2033
Table 23: North America Market Value (US$ Mn) Opportunity Analysis, by Disorder, 2018 to 2022
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by Disorder, 2023 to 2033
Table 25: North America Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022
Table 26: North America Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033
Table 27: North America Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2018 to 2022
Table 28: North America Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033
Table 29: North America Market Value (US$ Mn) Analysis, by Distribution Channel, 2018 to 2022
Table 30: North America Market Value (US$ Mn) Analysis, by Distribution Channel, 2023 to 2033
Table 31: North America Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2018 to 2022
Table 32: North America Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2023 to 2033
Table 33: Latin America Market Value (US$ Mn) Analysis, by Region, 2018 to 2022
Table 34: Latin America Market Value (US$ Mn) Analysis, by Region, 2023 to 2033
Table 35: Latin America Market Value (US$ Mn) Opportunity Analysis, by Region, 2018 to 2022
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by Region, 2023 to 2033
Table 37: Latin America Market Value (US$ Mn) Analysis, by Disorder, 2018 to 2022
Table 38: Latin America Market Value (US$ Mn) Analysis, by Disorder, 2023 to 2033
Table 39: Latin America Market Value (US$ Mn) Opportunity Analysis, by Disorder, 2018 to 2022
Table 40: Latin America Market Value (US$ Mn) Opportunity Analysis, by Disorder, 2023 to 2033
Table 41: Latin America Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022
Table 42: Latin America Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033
Table 43: Latin America Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2018 to 2022
Table 44: Latin America Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033
Table 45: Latin America Market Value (US$ Mn) Analysis, by Distribution Channel, 2018 to 2022
Table 46: Latin America Market Value (US$ Mn) Analysis, by Distribution Channel, 2023 to 2033
Table 47: Latin America Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2018 to 2022
Table 48: Latin America Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2023 to 2033
Table 49: Europe Market Value (US$ Mn) Analysis, by Region, 2018 to 2022
Table 50: Europe Market Value (US$ Mn) Analysis, by Region, 2023 to 2033
Table 51: Europe Market Value (US$ Mn) Opportunity Analysis, by Region, 2018 to 2022
Table 52: Europe Market Value (US$ Mn) Opportunity Analysis, by Region, 2023 to 2033
Table 53: Europe Market Value (US$ Mn) Analysis, by Disorder, 2018 to 2022
Table 54: Europe Market Value (US$ Mn) Analysis, by Disorder, 2023 to 2033
Table 55: Europe Market Value (US$ Mn) Opportunity Analysis, by Disorder, 2018 to 2022
Table 56: Europe Market Value (US$ Mn) Opportunity Analysis, by Disorder, 2023 to 2033
Table 57: Europe Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022
Table 58: Europe Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033
Table 59: Europe Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2018 to 2022
Table 60: Europe Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033
Table 61: Europe Market Value (US$ Mn) Analysis, by Distribution Channel, 2018 to 2022
Table 62: Europe Market Value (US$ Mn) Analysis, by Distribution Channel, 2023 to 2033
Table 63: Europe Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2018 to 2022
Table 64: Europe Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2023 to 2033
Table 65: Asia Pacific Market Value (US$ Mn) Analysis, by Region, 2018 to 2022
Table 66: Asia Pacific Market Value (US$ Mn) Analysis, by Region, 2023 to 2033
Table 67: Asia Pacific Market Value (US$ Mn) Opportunity Analysis, by Region, 2018 to 2022
Table 68: Asia Pacific Market Value (US$ Mn) Opportunity Analysis, by Region, 2023 to 2033
Table 69: Asia Pacific Market Value (US$ Mn) Analysis, by Disorder, 2018 to 2022
Table 70: Asia Pacific Market Value (US$ Mn) Analysis, by Disorder, 2023 to 2033
Table 71: Asia Pacific Market Value (US$ Mn) Opportunity Analysis, by Disorder, 2018 to 2022
Table 72: Asia Pacific Market Value (US$ Mn) Opportunity Analysis, by Disorder, 2023 to 2033
Table 73: Asia Pacific Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022
Table 74: Asia Pacific Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033
Table 75: Asia Pacific Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2018 to 2022
Table 76: Asia Pacific Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033
Table 77: Asia Pacific Market Value (US$ Mn) Analysis, by Distribution Channel, 2018 to 2022
Table 78: Asia Pacific Market Value (US$ Mn) Analysis, by Distribution Channel, 2023 to 2033
Table 79: Asia Pacific Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2018 to 2022
Table 80: Asia Pacific Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2023 to 2033
Table 81: MEA Market Value (US$ Mn) Analysis, by Region, 2018 to 2022
Table 82: MEA Market Value (US$ Mn) Analysis, by Region, 2023 to 2033
Table 83: MEA Market Value (US$ Mn) Opportunity Analysis, by Region, 2018 to 2022
Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by Region, 2023 to 2033
Table 85: MEA Market Value (US$ Mn) Analysis, by Disorder, 2018 to 2022
Table 86: MEA Market Value (US$ Mn) Analysis, by Disorder, 2023 to 2033
Table 87: MEA Market Value (US$ Mn) Opportunity Analysis, by Disorder, 2018 to 2022
Table 88: MEA Market Value (US$ Mn) Opportunity Analysis, by Disorder, 2023 to 2033
Table 89: MEA Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022
Table 90: MEA Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033
Table 91: MEA Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2018 to 2022
Table 92: MEA Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033
Table 93: MEA Market Value (US$ Mn) Analysis, by Distribution Channel, 2018 to 2022
Table 94: MEA Market Value (US$ Mn) Analysis, by Distribution Channel, 2023 to 2033
Table 95: MEA Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2018 to 2022
Table 96: MEA Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2023 to 2033
List of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 04: Global Market Incremental $ Opportunity, 2023 to 2033
Figure 05: Global Market Share and BPS Analysis by Disorder, 2023 & 2033
Figure 06: Global Market Y-o-Y Growth Projections by Disorder, 2023 to 2033
Figure 07: Global Market Attractiveness Analysis by Disorder, 2023 to 2033
Figure 08: Global Market Value (US$ Mn) and Forecast by Peripheral Neuropathy, 2018 to 2033
Figure 09: Global Market Incremental $ Opportunity by Peripheral Neuropathy, 2023 to 2033
Figure 10: Global Market Value (US$ Mn) and Forecast by Autonomic Neuropathy, 2018 to 2033
Figure 11: Global Market Incremental $ Opportunity by Autonomic Neuropathy, 2023 to 2033
Figure 12: Global Market Value (US$ Mn) and Forecast by Proximal Neuropathy, 2018 to 2033
Figure 13: Global Market Incremental $ Opportunity by Proximal Neuropathy, 2023 to 2033
Figure 14: Global Market Value (US$ Mn) and Forecast by Focal Neuropathy, 2018 to 2033
Figure 15: Global Market Incremental $ Opportunity by Focal Neuropathy, 2023 to 2033
Figure 16: Global Market Share and BPS Analysis by Treatment, 2023 & 2033
Figure 17: Global Market Y-o-Y Growth Projections by Treatment, 2023 to 2033
Figure 18: Global Market Attractiveness Analysis by Treatment, 2023 to 2033
Figure 19: Global Market Share and BPS Analysis by Drug, 2023 & 2033
Figure 20: Global Market Y-o-Y Growth Projections by Drug, 2023 to 2033
Figure 21: Global Market Value (US$ Mn) and Forecast by Drug, 2018 to 2033
Figure 22: Global Market Incremental $ Opportunity by Drug, 2023 to 2033
Figure 23: Global Market Share and BPS Analysis by Radiotherapy, 2023 & 2033
Figure 24: Global Market Y-o-Y Growth Projections by Radiotherapy, 2023 to 2033
Figure 25: Global Market Value (US$ Mn) and Forecast by Radiotherapy, 2018 to 2033
Figure 26: Global Market Incremental $ Opportunity by Radiotherapy, 2023 to 2033
Figure 27: Global Market Share and BPS Analysis by Physiotherapy, 2023 & 2033
Figure 28: Global Market Y-o-Y Growth Projections by Physiotherapy, 2023 to 2033
Figure 29: Global Market Share and BPS Analysis by Region, 2023 & 2033
Figure 30: Global Market Y-o-Y Growth Projections by Region, 2023 to 2033
Figure 31: Global Market Attractiveness Analysis by Region, 2023 to 2033
Figure 32: North America Market Share and BPS Analysis by Country, 2023 & 2033
Figure 33: North America Market Y-o-Y Growth Projections by Country, 2023 to 2033
Figure 34: North America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 35: North America Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 36: North America Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 37: North America Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 38: North America Market Incremental $ Opportunity, 2023 to 2033
Figure 39: North America Market Share and BPS Analysis by Disorder, 2023 & 2033
Figure 40: North America Market Y-o-Y Growth Projections by Disorder, 2023 to 2033
Figure 41: North America Market Attractiveness Analysis by Disorder, 2023 to 2033
Figure 42: North America Market Share and BPS Analysis by Treatment, 2023 & 2033
Figure 43: North America Market Y-o-Y Growth Projections by Treatment, 2023 to 2033
Figure 44: North America Market Attractiveness Analysis by Treatment, 2023 to 2033
Figure 45: North America Market Value (US$ Mn) and Forecast by Drug, 2018 to 2033
Figure 46: North America Market Incremental $ Opportunity by Drug, 2023 to 2033
Figure 47: North America Market Value (US$ Mn) and Forecast by Radiotherapy, 2018 to 2033
Figure 48: North America Market Incremental $ Opportunity by Radiotherapy, 2023 to 2033
Figure 49: Latin America Market Share and BPS Analysis by Country, 2023 & 2033
Figure 50: Latin America Market Y-o-Y Growth Projections by Country, 2023 to 2033
Figure 51: Latin America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 52: Latin America Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 53: Latin America Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 54: Latin America Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 55: Latin America Market Incremental $ Opportunity, 2023 to 2033
Figure 56: Latin America Market Share and BPS Analysis by Disorder, 2023 & 2033
Figure 57: Latin America Market Y-o-Y Growth Projections by Disorder, 2023 to 2033
Figure 58: Latin America Market Attractiveness Analysis by Disorder, 2023 to 2033
Figure 59: Latin America Market Share and BPS Analysis by Treatment, 2023 & 2033
Figure 60: Latin America Market Y-o-Y Growth Projections by Treatment, 2023 to 2033
Figure 61: Latin America Market Attractiveness Analysis by Treatment, 2023 to 2033
Figure 62: Latin America Market Value (US$ Mn) and Forecast by Drug, 2018 to 2033
Figure 63: Latin America Market Incremental $ Opportunity by Drug, 2023 to 2033
Figure 64: Latin America Market Value (US$ Mn) and Forecast by Radiotherapy, 2018 to 2033
Figure 65: Latin America Market Incremental $ Opportunity by Radiotherapy, 2023 to 2033
Figure 66: Europe Market Share and BPS Analysis by Country, 2023 & 2033
Figure 67: Europe Market Y-o-Y Growth Projections by Country, 2023 to 2033
Figure 68: Europe Market Attractiveness Analysis by Country, 2023 to 2033
Figure 69: Europe Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 70: Europe Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 71: Europe Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 72: Europe Market Incremental $ Opportunity, 2023 to 2033
Figure 73: Europe Market Share and BPS Analysis by Disorder, 2023 & 2033
Figure 74: Europe Market Y-o-Y Growth Projections by Disorder, 2023 to 2033
Figure 75: Europe Market Attractiveness Analysis by Disorder, 2023 to 2033
Figure 76: Europe Market Share and BPS Analysis by Treatment, 2023 & 2033
Figure 77: Europe Market Y-o-Y Growth Projections by Treatment, 2023 to 2033
Figure 78: Europe Market Attractiveness Analysis by Treatment, 2023 to 2033
Figure 79: Europe Market Value (US$ Mn) and Forecast by Drug, 2018 to 2033
Figure 80: Europe Market Incremental $ Opportunity by Drug, 2023 to 2033
Figure 81: Europe Market Value (US$ Mn) and Forecast by Radiotherapy, 2018 to 2033
Figure 82: Europe Market Incremental $ Opportunity by Radiotherapy, 2023 to 2033
Figure 83: Asia Pacific Market Share and BPS Analysis by Country, 2023 & 2033
Figure 84: Asia Pacific Market Y-o-Y Growth Projections by Country, 2023 to 2033
Figure 85: Asia Pacific Market Attractiveness Analysis by Country, 2023 to 2033
Figure 86: Asia Pacific Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 87: Asia Pacific Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 88: Asia Pacific Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 89: Asia Pacific Market Incremental $ Opportunity, 2023 to 2033
Figure 90: Asia Pacific Market Share and BPS Analysis by Disorder, 2023 & 2033
Figure 91: Asia Pacific Market Y-o-Y Growth Projections by Disorder, 2023 to 2033
Figure 92: Asia Pacific Market Attractiveness Analysis by Disorder, 2023 to 2033
Figure 93: Asia Pacific Market Share and BPS Analysis by Treatment, 2023 & 2033
Figure 94: Asia Pacific Market Y-o-Y Growth Projections by Treatment, 2023 to 2033
Figure 95: Asia Pacific Market Attractiveness Analysis by Treatment, 2023 to 2033
Figure 96: Asia Pacific Market Value (US$ Mn) and Forecast by Drug, 2018 to 2033
Figure 97: Asia Pacific Market Incremental $ Opportunity by Drug, 2023 to 2033
Figure 98: Asia Pacific Market Value (US$ Mn) and Forecast by Radiotherapy, 2018 to 2033
Figure 99: Asia Pacific Market Incremental $ Opportunity by Radiotherapy, 2023 to 2033
Figure 100: MEA Market Share and BPS Analysis by Country, 2023 & 2033
Figure 101: MEA Market Y-o-Y Growth Projections by Country, 2023 to 2033
Figure 102: MEA Market Attractiveness Analysis by Country, 2023 to 2033
Figure 103: MEA Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 104: MEA Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 105: MEA Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 106: MEA Market Incremental $ Opportunity, 2023 to 2033
Figure 107: MEA Market Share and BPS Analysis by Disorder, 2023 & 2033
Figure 108: MEA Market Y-o-Y Growth Projections by Disorder, 2023 to 2033
Figure 109: MEA Market Attractiveness Analysis by Disorder, 2023 to 2033
Figure 110: MEA Market Share and BPS Analysis by Treatment, 2023 & 2033
Figure 111: MEA Market Y-o-Y Growth Projections by Treatment, 2023 to 2033
Figure 112: MEA Market Attractiveness Analysis by Treatment, 2023 to 2033
Figure 113: MEA Market Value (US$ Mn) and Forecast by Drug, 2018 to 2033
Figure 114: MEA Market Incremental $ Opportunity by Drug, 2023 to 2033
Figure 115: MEA Market Value (US$ Mn) and Forecast by Radiotherapy, 2018 to 2033
Figure 116: MEA Market Incremental $ Opportunity by Radiotherapy, 2023 to 2033
Who worked on this report
Preview the report firsthand - request a free sample
Free SampleGet the brochure for pricing and purchase details
Download PDF